StudySphere provides fast, easy and free access to a wide variety of research-quality child-safe websites organized for education online from home, school, study abroad and home school. StudySphere’s goal is to help students, teachers, librarians, and other researchers find both highly targeted and closely related information quickly.
Votes:0 Skip to content Home About us Careers Investors Media Partnering Products Research Responsibility Contact us Welcome to AstraZeneca's international website. As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare. Latest news " src="sites/7/images/contentArrow.gif"> 19 November 2007 : EPO Rules AstraZeneca MUPS® Patent Valid " src="sites/7/images/contentArrow.gif"> 16 November 2007 : Seroquel XRT Receives Approval from FDA for Maintenance Treatment of Schizophrenia " src="sites/7/images/contentArrow.gif"> 9 November 2007 : CRESTOR® Now Indicated To Slow The Progression Of Atherosclerosis In Patients With Elevated Cholesterol Features Our biologics Read More Go to Site
Votes:0 Select a Country | Site Map | Contact Us Print This Page | Back to Web Page Home About Abbott Products Science & Innovation Global Citizenship Careers News & Media Investor Relations Global Licensing HIV/AIDS and Abbott Abbott is fighting HIV/AIDS all over the world by expanding access to
treatment, supporting children and strengthening health care systems. Learn more about this important work. News Abbott's HUMIRA® Receives Positive Opinion from EMEA for Treatment of Moderate to Severe Plaque Psoriasis Abbott Partners with Operation Smile to Support 40 Medical Missions in 25 Countries Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra® (lopinavir/ritonavir) Tablet for Pediatric HIV Patients View more news... Features Abbott Targets Neuronal Nicotinic Read More Go to Site
Votes:0 Welcome to searlehealthnet.com Healthnet Health Insurance Kaiser Permanente Medical Insurance Health Insurance Quote Affordable Health Insurance Individual Health Insurance Cheap Health Insurance Unicare Aetna Health Insurance Aetna Insurance Annuities Temporary Insurance Pet Insurance Home-auto Combined Insurance Property Insurance Disability Insurance Read More Go to Site
Votes:0 home contact us francais careers TSX:DDS NASDAQ:DDSS profile overview vision and business model board of directors officers locations investors press releases financial reports regulatory filings corporate governance stock information events analyst coverage investor contact products overview tramadol tramadol global commercialization tramadol posters and presentations tramadol line extensions pain medication market pipeline trazodone abuse resistant formulations propofol partners overview licensing and distribution partners current partnerships partnering contacts technology overview Contramid Polymeric Nano-Delivery System media press releases events financial reports regulatory filings We are an emerging leader in optimizing the performance of small molecule drugs using our proprietary, Read More Go to Site
Votes:0 Prescription Drugs for Lung Diseases provides information on generic and brand name drugs available in Canada. How do particular drugs work in my body? Are there any unwanted or side effects? What precautions should I take? How do I take the medication? Prescription Drug Coverage in Canada . Your guide to reimbursement for prescription medications in Canada. Prescription drugs are approved by various governmental agencies federally and provincially. Access to Prescription Drugs in Canada: A Guide [PDF - 476KB] provides an overview of how prescription drugs are approved and made available in Canada. For a quick overview of prescription drugs, please consult the Access to Prescription Drugs in Canada: FAQ . For more information on treatments for a particular disease, look under the name of t Read More Go to Site
Votes:0 .gmnav { font-family:verdana,helvetica,arial, sans-serif; font-size: .7em; font-style: normal; text-decoration: none; color: #339999; margin-top: 8; margin-bottom: 8; margin-left: 4; margin-right: 16} Shop AACP About AACP Meetings Governance .gmnav { font-family:verdana,helvetica,arial, sans-serif; font-size: .7em; font-style: normal; text-decoration: none; color: #339999; margin-top: 8; margin-bottom: 8; margin-left: 4; margin-right: 16} AmJPharmEduc News Room For Deans For Faculty For Students & Applicants For Sections For SIGs Pharmacy Schools Resources Curricular Resource Center Issues and Advocacy Institutional Data Related Pharmacy Organizations If you are a member, please log in . ANNOUNCEMENTS The November edition of AACP News is now available online! [11/19/07] The November editio Read More Go to Site
Votes:0 information pages about HIV and AIDS from ... new on aidsinfonyc ... TAG Updates on the Merck HIV Vaccine Trial Download Adobe Acrobat Reader for free .')">TB Research & Development Report Interview series launched: Douglas Nixon Save the Date! 12/9/07 RIAA Awards Open letter on pricing of Isentress® TAGline September 2007 TAG comments on halted vaccine trial Satellite on TB/HIV: Battling the Dual Epidemic through Community Action Sign-on letter protests death in detention Guide to HCV/HIV Coinfection Download Adobe Acrobat Reader for free .')"> Statement on HIV/HCV Coinfection Letter re firing of SA Health Minister Activism and policy, basic science, newsletter, HIV treatments, complications (OIs). Research, new treatments, what's ahead. Online anonymous treatments database. Children with Read More Go to Site
Votes:0 Welcome! Alliance Pharmaceutical Corp. is a research and development company focused on transforming innovative scientific discoveries into novel therapeutic and diagnostic agents. We are pleased that you have taken the time to visit our Home Page, and we hope that the following information will introduce you to our company. Please pardon our construction -- Our website is under revision. General Information Contact and Investor Information History of Alliance Oxygent TM is an intravascular oxygen carrier in clinical development as a temporary "blood substitute" to reduce or eliminate the need for donor blood transfusions during surgery. Alliance News and Corporate Reports Press Releases SEC Filings Annual Reports: 2004 Annual Report - In PDF format; 482kb. Except for historical Read More Go to Site
Votes:0 Patient Resources | Email Sign-up | Contact Us #memoryticker{ width: 400px; filter: progid:DXImageTransform.Microsoft.GradientWipe(GradientSize=1.0 Duration=1.0 WipeStyle=0) } News, SEC filings, presentation archives, stock information THERAPEUTIC FOCUS Diabetes Obesity Amylin is dedicated to improving lives through the discovery, development and commercialization of innovative medicines for the treatment of diabetes and obesity. View or download our current annual report. View and download annual report REPLAY: BIOCOM Investor Conference (San Diego, CA) Thursday, November 1, 2007 9:30 a.m. PT / 12:30 p.m. ET REPLAY: Amylin Investor Conference Call Wednesday, October 31, 2007 8:30 a.m. ET / 5:30 a.m. PT NAASO Schedule of Presentations (New Orleans) October 20-24, 2007 REPLAY: Q3 2007 Quart Read More Go to Site
Votes:0 The Anesthesia Medication Guide is available in PDA iSilo3 format. The Palm PDA version requires iSilo3 document reader from www.isilo.com Updated version available from "MemoWare" www.memoware.com Search for "Anesthesia" and navigate to the site Home Page Read More Go to Site
Votes:0 Select an Issue from the Archive January 1972 - December 2007 AAC Accepts Current Issue: December 2007 Search for Articles ABOUT AAC INSTR. TO AUTHORS EDITORS SUBSCRIPTIONS ADVERTISING REPRINTS REVIEWER GUIDELINES MINIREVIEWS COPYRIGHT AND POSTING INFO SUBMIT MANUSCRIPTS REVIEWER PORTAL CDC SELECT AGENT INFO Other ASM Journals that may be of interest: Clin. Vaccine Immunol. Clin. Microbiol. Rev. J. Clin. Microbiol. ALL ASM JOURNALS For an alternate route Read More Go to Site
Votes:0 Antiviral Agents Bulletin The Antiviral Agents Bulletin ceased publication in March 2003. This site is archived (no longer updated). For 15 years (3/1988-3/2003), the Antiviral Agents Bulletin was the only periodical specializing inantiviral drug and vaccine development. The Bulletin covered all antiviral therapeutics, but the largest portion of news articles, patents, etc., concern HIV/AIDS-related antiviral drugs and vaccines. Articles in the Antiviral Agents Bulletin described and assessed commercial and scientific developments, treatment advances and trends, patents and technology transfers, federal and regulatory activities, and information resources. Abstracts for all antiviral and virus-related U.S. patents and international patent disclosures were also provided. An annual review i Read More Go to Site
Votes:0 About Introduction to the Society Objectives of the Society Officers Board of Directors Past Presidents Committees Bylaws ASCPT Strategic Plan ASCPT Staff ASCPT Privacy Policy ASCPT Mailing List Directions to ASCPT ASCPT Conflict of Interest Policy Annual Meeting ASCPT Awards Career Center Education Training Programs Educational Resources Fellowship Opportunities Mentoring Program Join ASCPT Join Today Categories of Membership Advantages of Membership Membership Renew 2008 Dues Scientific Sections Update Information Request Information Online Giving Refer a Colleague 2008 Member Get A Member Campaign Get Involved! Newsroom Home Read the December 2007 issue of CPT online! Submit a Manuscript Become a Reviewer About CPT FAQ ASCPT Seeks Mentors and Proteges for Mentoring Program ASCPT is seek Read More Go to Site
Votes:0 Home Index A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9 Read More Go to Site
Votes:0 Contact Us Product Guide Drug Information Site Map $51.55 +$0.59 (Up 0.8%) Volume: 814,700 Nov 20, 2007 Barr Confirms Patent Challenge of Focalin(R) XR... Nov 08, 2007 Barr Reports Third Quarter 2007 GAAP Earnings of $0.36 Per Share;... Jan 04, 2008 Barr Pharmaceuticals, Inc. at Morgan Stanley Pharmaceutical CEOs Unplugged Conference Jan 08, 2008 Barr Pharmaceuticals, Inc. at JPMorgan Healthcare Conference Barr Pharmaceuticals, Inc. Terms of Use Legal Notice Privacy Policy Mission Corporate Profile Business Strategies Annual Report Facilities Government Affairs Barr History Generic Business Overview Generic Business Strategies Key Generic Products Generic Product Pipeline Generic Sales Process FAQ About Generics Generic Drug FDA Approval Process History of Generic Industry Industry Links P Read More Go to Site
Votes:0 Attention: Your browser does not support Javascript, or Javascript support has been disabled. This web site utilizes the latest Internet technology, and in order to experience the full functionality of this web site you will need to ensure that Javascript is enabled. --> Bayer Global Bayer US BayerNet General Conditions of Use Privacy Statement Imprint Click here for symptoms Congestion Common Cold Flu Cuts/Scrapes/Burns Insect Bites Skin Irritation Acid Indigestion with Pain Constipation Heartburn with Pain Sour Stomach with Pain Heart Attack Stroke Prevention Supplements Vitamin Needs Minor Arthritis Pain Back Ache Muscular Aches Headache Hangover Toothache Cold Sores Lice Menstrual Pain Select a brand for more Read More Go to Site
Votes:0 Contact Products Investor Relations Careers Press Resources Clinical Trials This year marks a significant moment for the pharmaceutical industry. Berlex Laboratories has been integrated into Bayer HealthCare, and we are operating as an integrated specialty pharmaceuticals business under a new name, Bayer HealthCare Pharmaceuticals. The Bayer name is one of the most-recognized brands in healthcare, built on the company's long history of providing medicines that healthcare providers and patients can trust. By combining the strengths of two of the most recognized and well respected pharmaceutical companies in the world - Bayer and Berlex - Bayer HealthCare Pharmaceuticals has become a new leader in the specialty pharmaceutical arena. This is an exciting time for all of us - be it for patients Read More Go to Site
Votes:0 Detecting macromedia flash, please wait... Please turn on javascript in your browser, then click here to continue. If you wish to continue without Flash, click here. Read More Go to Site
Votes:0 contact info | locations | site map investor relations | careers Company Products Patients News Highlights Biogen Idec and Neurimmune Therapeutics Announce Alliance to Develop Treatments for Alzheimer's Disease More CHMP Adopts Negative Opinion on Appeal on European Application for Natalizumab for The Treatment of Crohn's Disease More Biogen Idec's Baminercept, the First Lymphotoxin-β Pathway Inhibitor in Development, Shows Promise in Patients with Rheumatoid Arthritis More Phase II Clinical Trial Results for ADENTRI Published in Journal of the American College of Cardiology More Friday, June 1 10:00am ET Biogen Idec to present at the Sanford and Bernstein Conference Webcast Friday, June 1 11:00am ET Biogen Idec to present at the Sanford and Bernstein Conference - Breakout Session Web Read More Go to Site
Votes:0 Biotechnology Information Institute The Biotechnology Information Institute (BII) develops unique, high-end information resources and provides consulting serving critical needs of the biotechnology and pharmaceutical communities. As a sole proprietorship, Ronald A. Rader, President, is responsible for all of BII's products. Current, former and upcoming publications include: Biopharmaceutical Products in the U.S. and European Markets : the only biopharmaceutical products reference book (6th edition, 2 vol., 1602 pages, Sept. 2007) Antiviral Agents Bulletin : for 15 years (1987-2003) [former]; the only periodical specializing in antiviral drug and vaccine development (over 5,300 pages) Federal Bio-Technology Transfer Directory : [former]; covering all federal, e.g., NIH, inventions and techn Read More Go to Site
Votes:0 CONTACT US | EMPLOYEE LOG IN | CLIENT SERVICES | GLOSSARY | SITE MAP Precision Therapeutics is an oncology Services Company dedicated to the individualization of cancer therapy. Precision is a leader in the development and delivery of treatment support tools that assist physicians and benefit cancer patients. What makes ChemoFx Assay different? ChemoFx? is a cell-based test that examines the likelihood of specific patient's tumor response to a broad range of existing, novel and combination chemotherapies. ChemoFx? provides a direct insight into which chemotherapy regimens may be most effective for each patient. READ MORE ? My most pressing patient was a 28-year-old woman who had recurrent ovarian cancer and was actually near death's door at the time of a surgery for an intestinal blockage. Read More Go to Site
Votes:0 Welcome to our Non-Commercial, Ad Free website :-) We are an International Christian Organization of Volunteers from across the Globe who offer support and information, free of charge to all people regardless of Race, Creed or Religious believes. The information on this website is current and has been thoroughly researched before being published. We are a non-commercial website and we do not sell any products or information. Getting Better Every Day About Us | Privacy Policy Revised: November 05, 2007 . Information Directory Alternative Medicine. Anal Cancer Bladder Cancer Bone Marrow Resgistry Brain Cancers Breast Cancer Breast, Colon, Testicular Self Tests Cancer Cancer Picture-Non Graphic Cancer Terms and Words Cancer Types Carcinoma Cancers Cell Suicide Characteristics of Cancer Chat R Read More Go to Site
Votes:0 New look coming soon -- try the beta version Home Search Listings Resources Help What's New About ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research in human volunteers. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. The information provided on ClinicalTrials.gov should be used in conjunction with advice from health care professionals. Before searching, you may want to learn more about clinical trials. INVESTIGATOR NOTE: Investigators wishing to register trials should refer to http://prsinfo.clinicaltrials.gov. Search Clinical Trials Example: heart attack, Los Angeles Tips Search within Specific Fields Focused Search - search by disease, lo Read More Go to Site
Votes:0 In English | En espaÑol Quick Links Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports NIH Calendar of Events Scientific meetings EspaÑol InformaciÓn en espaÑol Questions about cancer? 1-800-4-CANCER LiveHelp® online chat --> NCI Highlights Report Finds Cancer Death Rate Decline Doubling The Nation's Investment in Cancer Research FY 2008 Statement on Fiscal Year 2008 Budget Request President's Cancer Panel Annual Report: 2006-2007 Cancer Trends Progress Report: 2005 Update NCAB Working Group Report on Biomedical Technology caBIG: Connecting the Cancer Com Read More Go to Site
Votes:0 Disease Index BRAIN BREAST CUTANEOUS Kaposi's Melanoma GASTROINTESTINAL Anus Colorectal Esophageal Gastric or Small Bowel Pancreas GENITOURINARY: Bladder Prostate Renal Testicular GYNECOLOGIC Endometrial Cervical Ovarian Head And Neck LEUKEMIAS-ADULT Acute Lymphocytic Chronic Lymphocytic Acute Myelogenous Chronic Myelogenous LUNG Non Small Cell Small Cell LYMPHOMA Hodgkin's Non Hodgkin's Multiple Myeloma SARCOMA Bony/Osteo Soft Tissue [ Top Of Page | DoseCalc Index ] Read More Go to Site
Votes:0 Back to Homepage >> celebrate with us about us • contact us • subscribe/renew • advertise • classifieds • reprints Read More Go to Site
Votes:0 Home | Search | Secure Logon | Contact Products | R&D | News | About | Careers | Investors Quick Links Job Search Corporate Citizenship Access to Medicines Product Pipeline Corporate Governance Clinical Trial Registry ? For additional navigation you must have JavaScript enabled. Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs. Eli Lill Read More Go to Site
Votes:0 Elsevier.nl woensdag 21 november 2007 Home Nieuwsbrief RSS Contact Log in Type een zoekterm en klik 'Zoek'... Nieuws van 06:48 Opinie Commentaren Ellian & De Winter Brussels Blog Simon Rozendaal Oh oh Den Haag Op de catwalk Misdaad & Straf Vrouw van de Wereld Columns Syp Wynia Reacties Dossiers Rita Verdonk Alles over de veelbewogen en veelbesproken politieke carrière van Rita Verdonk. Dossier Willem Holleeder Alle ins en outs van het monsterproces tegen Willem Holleeder Diabetes Diabetes is een volksziekte in opkomst. De klachten zijn moeilijk te herkennen. Hier leest u alles. Onderzoeken Een overzicht van alle recente Elsevier-onderzoeken Alle dossiers Lifestyle Gezondheid & Gezin Eten & Uitgaan Mode & Wonen Auto & Reizen Weekblad Deze week Elsevier Thema Spe Read More Go to Site
Votes:0 EUDERMA - VALPHARMA GROUP SPECIALISTS IN MODIFIED RELEASE CAPSULES AND TABLETS Click here for more information For any enquiry please contact us at the following addresses: Valpharma s.a. Euderma S.p.A. Via Ranco, 112 Via Rigardara 27-29 47031 Serravalle 47040 Cerasolo di Coriano Repubblica di San Marino Rimini (Italy) E-mail: valpharma@omniway.sm E-mail: euderma@infotel.it Tel: (From Italy) (From other countries) 0549 900936 +378 900936 Tel: +39 (0)541 759264 Fax: (From Italy) (From other countries) 0549 901409 +378 901409 Fax: +39 (0)541 756006 Telex: 518521 euderm-i Read More Go to Site
Votes:0 TABLEMAKER MEDIA CENTER STATE CENTER PUBLICATIONS OUR WORK Family Planning Perspectives Volume 32, Number 2, March/April 2000 DIGEST Fertility Drugs Do Not Raise Breast, Ovarian Or Uterine Cancer Risk Women who take ovulation-inducing drugs in conjunction with in vitro fertilization are not at increased risk of developing breast, ovarian or uterine cancer, according to a large Australian cohort study. 1 However, women who seek treatment but do not take fertility drugs have more than twice the expected incidence of uterine cancer, and women with unexplained infertility have elevated rates of uterine and ovarian cancer. The study was based on data on 29,700 women who registered for treatment at 10 in vitro fertilization clinics before January 1, 1994. Clinic records provided background infor Read More Go to Site
Votes:0 The Yellow Pages Phone Book and Phone Directory Business Phone Directory People Phone Book Web Search Find a Business: Enter a City: Choose a State: Select... Alabama Alaska Arizona Arkansas California Colorado Connecticut D.C. Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Category Name Find a Person: Enter a City: Choose a State: Select... Alabama Alaska Arizona Arkansas California Colorado Connecticut D.C. Delaware Florida Georgia H Read More Go to Site
Votes:0 Search Powered by Google A-Z Index | Site Map Products FDA Regulates Food Foodborne Illness, Nutrition, Dietary Supplements... Drugs Prescription, Over-the-Counter, Generic... Medical Devices Pacemakers, Contact Lenses, Hearing Aids... Biologics Vaccines, Blood Products... Animal Feed and Drugs Livestock, Pets... Cosmetics Safety, Labeling... Radiation-Emitting Products Cell Phones, Lasers, Microwaves... Combination Products New for Health Professionals Learn More & Subscribe Consumer Health Information Getting Up to Date on Glucose Meters All Consumer Health > > FDA News FDA Key Initiatives FDA Issues Early Communication for Chantix FDA Approves Nexavar for Patients with Inoperable Liver Cancer FDA Awards Grants to Further Food Safety Approximately $2 Million of Potentially Harmful Read More Go to Site
Votes:0 Home Contact Us Site Index Search On October 15, 2007, Genentech was named a " top employer in the biotechnology, biopharmaceutical, pharmaceutical and related industries" by Science magazine — a ranking based on the company's "commitment to innovative thinking throughout the product pipeline, from the laboratory to the clinic or marketplace." This is the sixth year Genentech has appeared on the list. On September 25, 2007, Working Mother magazine named Genentech one of the " 100 Best Companies for Working Mothers ." The list identifies companies who are "using company-wide benefits and programs to ensure the retention and advancement of working mothers." This is the 15th year Genentech has appeared on the list. 75.12 -0.02 11.20.07 16:01:00 20 min delay Genentech's mission is to be Read More Go to Site
Votes:0 We have detected that your browser does not have Javascript turned on. This site is optimized for Javascript. You may experience difficulties browsing certain parts of the site. Genzyme Corporate Pharmaceuticals Home Search Contact Us Genzyme Websites Genzyme Pharmaceuticals is one of the first businesses acquired by Genzyme... more > Genzyme Pharmaceuticals and Brookwood Pharmaceuticals Enter Broad Collaboration in Drug Delivery with an Initial Focus on Peptide Delivery Genzyme Pharmaceuticals, a business unit of Genzyme Corporation, and Brookwood Pharmaceuticals, Inc., today announced a broad collaboration to develop novel drug delivery solutions, with an initial focus on peptide delivery. The partnership offers customized solutions for parenteral formulations by combining expertise i Read More Go to Site
Votes:0 Entire Site Articles/Fact Sheets Ask the Experts Conference Coverage --> TREATMENT TOPICS Treatment Basics Approved HIV Medications by Class Drug Interactions Medication Side Effects Drugs in Development Nucleoside/Nucleotide Analog Reverse Transcriptase Inhibitors (NRTIs) Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Protease Inhibitors (PIs) Fusion Inhibitors (FIs) and Other Entry Inhibitors --> This section is sponsored in part by: Twenty-nine medications have been approved by the U.S. government to fight HIV, with many more in development . To learn when and how they are used, read up on the basics about HIV medications and use the list below. HIV medications fall into several groups, or "classes." Each class attacks HIV a little differently, and has diverse risks and benefi Read More Go to Site
Votes:0 infodrug.com Related Searches Drug Rehab Free Drug Rehabilitation Cholesterol Lowering Drug Drug Information Center Drug Info Drug Medication 99.9% Guaranteed Uptime No Setup Fee or Annual Commitment Generous Storage & Bandwidth Free, Expert 24/7 Support And MUCH More! Flexible plans as low as $3.19/mo! Learn more... Sponsored Listings Manage Alzheimers Right Are you managing Dementia properly? Learn, Track & Improve Symptoms www.DementiaGuide.com Drug Detox Center Unique Approach & Proven Methods - Highest Success Rate in the Country PassagesMalibu.com Drug Interaction Center Learn about commonly misunderstood food-drug interactions. www.druginteractioncenter.org Ionimine For Sale Prescription Strength Appetite Suppressant. $10 off 2 Bottles! www.Ionimine.com Drug Serialization Value? Gai Read More Go to Site
Votes:0 J ournal of P harmacy & P harmaceutical S ciences .... ISI Impact Factor, 2.042 Editor , Fakhreddin Jamal i A free and open access peer-reviewed online journal since 1998 — the first in the field Cited in major citation lists : Chemical Abstracts Current Contents Embase Index Medicus Library & Archives Canada PubMed Current Issue Special Memorial Issue - Dr. Antoine Noujaim Archives Editorial Staff Associate Editors Editorial Board Author Instructions Manuscript Index CSPS Home Published by the C anadian S ociety for P harmaceutical S ciences Copyright ? 1997 CSPS 10th International Symposium on Pharmaceutical Sciences Read More Go to Site
Votes:0 L ocum I nternational G roup Please Choose Your Region LIG L ocum USA L ocum Euro www.locum USA .com www.locum Euro .com LIG Quick Menu - USA International Journal of Generic Drugs Handbooks Download Area Free Complementry Journal Issue Article of the Month Pharmaceutical Conferences IAGIM CENTER - Members Only Handbook Catalog Frequently Asked Questions Millennium Special Offer Download a Proforma Invoice IAGIM API Worldwide Search Quick Menu - EU International Journal of Drug Development Handbooks Download Area Free Complementry Journal Issue Article of the Month Pharmaceutical Conferences IAGIM CENTER USA - Members Only Handbook Catalog Frequently Asked Questions Millennium Special Offer Download a Proforma Invoice IAGIM Active Substance Search Int.J. Generic Drugs Worldwide sites Couri Read More Go to Site
Votes:0 Before you continue viewing this web site, we suggest that you go to "My Story" by Nelson Vergel for background information. Nelson's personal story will give you a basic understanding of how anabolic therapies, nutrition, and exercise are used in the fight against HIV. Read the Baltimore Sun interview with Nelson. Nelson Vergel's Survival Blog Michael Mooney, Editor & Publisher of this site. More info... www.michaelmooney.net • Compounded Nandrolone (Deca Durabolin) Usage Increases 30 Percent After Watson Stops Production • Compounding Pharmacies That Make Nandrolone • Click">Survey: Impact of Lipodystrophy on Quality of Life and Self-Esteem • Watson Quits Nandrolone Production And Savient Stops Oxandrin's Patient Assistance Program • Anabolic Hormones Availa Read More Go to Site
Votes:0 US Patient Programs Patient Assistance Program Prescription Discount Program Vaccine Patient Assistance Program Medicare Prescription Drug Coverage Corporate Responsibility Commitment to Communities Enabling Access Medical Outreach Program Patients & Caregivers Disease Education Web sites MerckSource Healthcare Professionals Disease Education Web sites MerckServices MerckVaccines.com Clinical Trials Conducting Clinical Trials Merck Sponsored Clinical Trials Popular Locations Products Careers 2006 Annual Review About Merck The text resize requires Javascript to be enabled. Please enable Javascript on your browser or use the browser text size controls --> NYSE | MRK 57.9200 | -0.3300 4:04 PM ET | 20 Nov 2007 Product News Read the latest news on Merck medicines and vaccines Research & Develop Read More Go to Site
Votes:0 FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA FDA Backgrounder May 3, 1999 Updated August 2005 Milestones in U.S. Food and Drug Law History From the beginnings of civilization people have been concerned about the quality and safety of foods and medicines. In 1202, King John of England proclaimed the first English food law, the Assize of Bread, which prohibited adulteration of bread with such ingredients as ground peas or beans. Regulation of food in the United States dates from early colonial times. Federal controls over the drug supply began with inspection of imported drugs in 1848. The following chronology describes some of the milestones in the history of food and drug regulation in the United States. 1820 Eleven physicians meet in Washington, D.C., to establish the U.S Read More Go to Site
Votes:0 Home | Careers | Site Map | Contact Us | Related Sites --> --> Home > Products Search by product name or NDC# Verbiage Placeholder for product info --> Product Quick Find Company Mylan Pharmaceuticals Mylan Technologies UDL Laboratories Therapeutic Category --> For information on products formerly marketed by MylanBertek, select one of the following: Choose Product Amnesteem Avita Biobrane Biobrane-L Biobrane Gloves Clozapine Digitek Flexzan Granulex Hydrocol II Kristalose Maxzide Maxzide-25 Mentax Nitrek Phenytoin Phenytek Proderm Sorbsan Dressings Sulfamylon Solution Sulfamylon Cream Mylan Product Guide Mylan offers one of the broadest and highest quality generic and specialty pharmaceutical product portfolios in the industry. The Company maintains a robust pipeline and provides a wid Read More Go to Site
Votes:0 ocpharma.com This domain is for sale! Related Searches Online Pharmacy Online Canada Pharmacy Canadian Pharmacy Canadian Pharmacy Online Viagra Online Pharmacy Canada Pharmacy Online Prescription Cheap Online Pharmacy Uk Viagra Internet Pharmacy Prescription Phentermine Online Pharmacy Mail Order Pharmacy Prescription Discount Online Pharmacy 30 Discount Favorite Categories Cold Medication Zinc Mucinex Airborne Sudafed Cold Medicine Hair Loss Medication Finasteride Medical Hair Restoration Minoxidil Alopecia Areata DHT Blockers Birth Control Medication Birth Control Birth Control Pill Ortho Evra Lawsuit Yasmin Ru486 Diabetes Medication Diabetic Medication Natural Medicine for Diabetes Herbal Medicine for Diabetes Diabetic Syringe Med Mini Pump Herpes Medication Herpes Herpes Medicine Lysin Read More Go to Site
Votes:0 --> Pediatric Cardiology Pediatric Cardiothoracic Surgery Pediatrics Cardiovascular Disorders (Pediatrics) Children's Hospital Heart & Vascular Programs --> --> --> Pediatric Cardiovascular Services Program Description Rush Children’s Hospital provides complete clinical services for the diagnosis and treatment of congenital and acquired heart disease in children and young adults. We believe in the team approach, and often bring together diverse pediatric specialists to provide children with the best care. Our board-certified pediatric cardiologists use the latest in care, including cardiac catheterizations. When surgery is required, pediatric cardiovascular surgeons at Rush offer the latest surgical techniques for the repair of heart, lung and chest wall defects. Rush is dedicated to Read More Go to Site
Votes:0 help + privacy policy + contact us + links + home advanced search ---> ---> APhA News APhA Views Behind-the-Counter Drug Status as Way to Improve Access to Care, Medication Use... More Info ›› Statement to FDA Regarding Behind-The-Counter Drug Status... More Info ›› APhA Applauds Unified Work of the Profession on MTM CPT Codes... More Info ›› APhA Foundation Receives Great Moments in Pharmacy Collection... More Info ›› APhA Recommends FDA Improve Pediatric OTC Labeling... More Info ›› Pharmacy Today Feature Articles Lessons of a bias case: communication matters... More Info ›› OTCs Today: Ensuring safe analgesic use during pregnancy... More Info ›› MTM for every patient, every day... More Info ›› Read More Go to Site
Votes:0 Home | Site map | Elsevier websites | Alerts --> --> Advanced Product Search Products Pharmacological Research Journal information Product description Editorial board Abstracting/indexing Special issues and supplements Subscription information Bibliographic and ordering information Conditions of sale Dispatch dates Journal related information Impact factor Most downloaded articles Other journals in same subject area Related publications Support & contact About Elsevier Select your view SiteStat.jsp Read More Go to Site
Votes:0 Home Department Faculty Staff Graduate Program Undergraduate Program Computing Science Resources School of Medicine Stony Brook Useful Links Web of Science Ovid Webcat Course Information Weather International Services Phone Book Search Stony Brook Search the Internet Solar System Blackboard Web Mail Archon (service requests) Pharmacological Sciences Seminars Monthly Seminar Flyer Calendars Graduate Program Calendar Registrar's Office Academic Calendar Stony Brook Calendar of Events Schedules Conference Rooms Schedules Stony Brook University News Top News General University News Stony Brook Medical Center/Health Care News Research News Stony Brook Press Clips About Stony Brook University Fast Facts Campus Maps Directions Athletics Welcome Center Web site Last Updated ( Tuesday, 23 October 2 Read More Go to Site
Votes:0 Serving the Patient and Health Professional - please select - Site Index PharmWeb and its Services How to Add/Edit Links Contact PharmWeb - Appointments Discussion Forum Conference Calendar Chat World Drug Alert Patient Information Directory of Health Professionals Schools of Pharmacy Directory PharmWeb Yellow Web Pages Government and Regulatory Bodies PharmWeb Virtual Library Societies Newsgroups Continuing/Further Education Special Interest Pages UK Pharmacies Database - Pharmacy and the Internet History of PharmWeb Internet Directory What's New Access Statistics Problem Solver Comments and Suggestions Authors and Acknowledgements Organisations on PharmWeb Plug-ins - EPSA ICH IPSF Paracetamol Information Centre PDMS Since its launch in 1994 PharmWeb has developed into the premier online Read More Go to Site
Votes:0 Serving the Patient and Health Professional - please select - Site Index PharmWeb and its Services How to Add/Edit Links Contact PharmWeb - Appointments Discussion Forum Conference Calendar Chat World Drug Alert Patient Information Directory of Health Professionals Schools of Pharmacy Directory PharmWeb Yellow Web Pages Government and Regulatory Bodies PharmWeb Virtual Library Societies Newsgroups Continuing/Further Education Special Interest Pages UK Pharmacies Database - Pharmacy and the Internet History of PharmWeb Internet Directory What's New Access Statistics Problem Solver Comments and Suggestions Authors and Acknowledgements Organisations on PharmWeb Plug-ins - EPSA ICH IPSF Paracetamol Information Centre PDMS Since its launch in 1994 PharmWeb has developed into the premier online Read More Go to Site
Votes:0 PhRMA: New Medicines. New Hope. Disease is our enemy. Working to save lives is our job. En Español | Members Area Please click here and install the flash plugin to get a better view of this website. About PhRMA Medicines in Development Patient Assistance Programs Publications News Room Safety Innovation Education Issues Need Help Paying For Your Medicines? Health Questions Did You Know? In 1980, PhRMA's member companies invested $2 Billion in research and development of medicines. Direct To Consumer Ads Your Opinion Matters More Innovation.org Straight Talk From PhRMA's Billy Tauzin Helping patients live longer, healthier lives. > MORE Health In High Definition Healthcare Now Updates It's Flu Season PhRMA Press Releases 10.23.07 Help For California Fire Evacuees Possible Through P Read More Go to Site
Votes:0 PROPHYLAXIS SURGICAL PROPHYLAXIS A single dose of a parenteral antibiotic given at induction or up to 30 minutes before induction usually provides adequate tissue concentrations for several hours. Antibiotic prophylaxis should therefore be given during this time period. Studies have shown that prophylaxis administered after commencement of surgery is of far less benefit. When surgery is prolonged or massive blood loss occurs, a second dose is advisable. Post operative doses of prophylactic drugs are unnecessary. General surgery with possible GIT contamination, including appendicitis co-amoxiclav 1,2g as a single dose Cardiac and vascular surgery cefazolin 1g as a single dose Further doses of 500mg may be given 8 hourly for up to 24 hours or extended to 48 hours if multiple lines are in pla Read More Go to Site
Votes:0 ADVERTISEMENT HOME News & Features Top 10 Sites Cancer Centers Ask An Expert My Community News Letter Contact Us Get Involved Site Index Welcome To sign in, click here! To create an account, click here! --> • AIDS Related • Bladder Cancer • Brain Tumor • Breast Cancer • Carcinoid Tumors • Cervical Cancer • Colorectal Cancer • Endometrial Cancer • Esophageal Cancer • Head and Neck • Kidney Cancer • Leukemia • Liver Cancer • Lung Cancer • Lymphoma • Melanoma • Multiple Myeloma • Ovarian Cancer • Pancreatic Cancer • Prostate Cancer • Skin Cancer • Sarcoma • Stomach Cancer • Testicular Cancer • Thyroid Cancer • Pediatric Cancers Other Cance Read More Go to Site
Votes:0 HOME | PAST ISSUES | TOPIC COLLECTIONS | Advanced Search CME | Physician Jobs | E-Mail Alerts | Register | Subscribe Please sign in for full text and personal services Subscribe Renew Register Submit a Manuscript or Letter Authors Customers Institutions/Libraries Reviewers NEJM Tools CME Personal Archive PDA Services E-Mail Alerts Physician Jobs Edit Your Information Access Outside U.S. Features at nejm.org Convention Schedule NEJM Information Privacy Policy Reprints Editors & Publishers Permissions Info Editorial Policies Advertising Policies Copyright Terms See All Features Contact Us NEJM Mobile Article Feeds Most Popular end obsolete --> November 15, 2007 FULL TABLE OF CONTENTS | THIS WEEK IN THE JOURNAL | AUDIO SUMMARY The Ongoing Regulation of Generic Drugs The Hatch–Waxman Act Read More Go to Site
Votes:0 Home | Featured Articles | Continuing Education | Subscribe SEARCH Advanced Search The Constipation Conundrum: What Now in Chronic Constipation and IBS-C This activity is supported by an educational grant from Sucampo Pharmaceuticals, Inc and Takeda Pharmaceuticals North America, Inc. Mission Possible: Taking CONTROL of Pediatric GERD This activity is supported by an educational grant from TAP Pharmaceutical Products Inc. Newer Insights Into the Prevention of the Common Cold This activity is supported by an educational grant from Procter & Gamble. Advanced Topics in Medicare Part D: Assisting Patients Eligible for Low-Income Subsidies This activity is supported by an educational grant from UnitedHealthcare. The Constipation Conundrum: What Now in Chronic Constipation and IBS-C? This activi Read More Go to Site
Votes:0 Venlafaxine Brand name: Effexor Drug monograph Contents Summary Pharmacology Indications Contraindications Warnings Precautions Adverse Effects Overdose Dosage Supplied Research Summary EFFEXOR Wyeth EFFEXOR XR Venlafaxine HCI Use: Serotonin and norepinephrine reuptake inhibitor. Major depressive disorder: Effexor: Adults, 75 mg/day in 2 or 3 divided doses with food. It may be desirable to start some patients at 37.5 mg/day for 4-7 days to allow new patients to adjust to the medication before increasing to 75 mg/day. After a few weeks, if necessary, increase gradually to 150 mg/day. If needed, a further increase may be made up to 225 mg/day (maximum dose for moderately depressed outpatients). Increments of up to 75 mg/day should be made at intervals of no less than 4 days. More severely de Read More Go to Site
Votes:0 '); newWin.document.writeln(' ') newWin.document.writeln(' '); newWin.document.writeln(' '); newWin.document.writeln(' '); newWin.document.writeln(' '); newWin.document.writeln(' '); newWin.document.writeln(' Read More Go to Site
Votes:0 wwilkins.com Related Searches: Medication | Cosmetic Surgery | Dental Care | Laser Eye Surgery | Medical Textbooks | Dat Test Related Searches Medication Cosmetic Surgery Dental Care Laser Eye Surgery Medical Textbooks Dat Test Bergey's Comprehensive Pharmacy Review Dental Admissions Test Human Anatomy DVD Emedicine Medical Textbooks Staphylococcus Aureus Search Sponsored Listings Wilkins genealogy www.onegreatfamily.com See your Wilkins Genealogy at OneGreatFamily! Free 7-day Trial Automatic Trailer Loading www.loading-automation.com Continuing to lead the way in ATLS Decrease Cost, Improve Productivity Bowers Wilkins www.Shopping.com Find great deals and save! Compare products, prices & stores. 10 Tips to Lose 9lbs Fast www.FatLoss4Idiots.com Lose 9 lbs every 11 Days with these 10 Easy R Read More Go to Site
Votes:0 We are pleased to inform you that the Company name has been changed from Amrad Corporation Limited to Zenyth Therapeutics Limited effective from 1 December 2005. In a short while you will automatically be re-directed to our new web site. If your browser does not automatically re-direct click here . Zenyth Therapeutics Limited ABN 37 006 614 375 576 Swan Street Richmond Victoria Australia 3121 Telephone 61 3 9208 4000 Facsimile 61 3 9208 4350 Read More Go to Site
StudySphere is an outstanding resource for homework help, special education, music school, cooking school, charter schools, art schools, technical schools, traffic school, film schools, catholic schools, etc.